QuadraMed Smart Identity Management and HIM Solutions Earn Top Rankings in 2009 Best in KLAS Report
January 19 2010 - 8:00AM
Business Wire
QuadraMed® Corporation (NASDAQ:QDHC), a leading provider of
healthcare information technologies and services that help turn
quality care into positive financial outcomes, today announced that
QuadraMed Smart Identity Management and Health Information
Management solutions earned high ratings in the 2009 Top 20 Best in
KLAS Awards Report released last month. QuadraMed Enterprise Master
Person Index (EMPI) and Quantim® Coding were rated number one and
number two in the EMPI and medical records coding software
categories, respectively. This study is conducted by KLAS
Enterprises, which independently monitors vendor performance
through the active participation of thousands of healthcare
organizations.
QuadraMed EMPI enables multi-facility healthcare organizations
to identify and resolve duplicate patient records stored within
their information systems. Quantim Coding uses knowledge-based
coding methodologies to provide the critical clinical, financial
and regulatory information coders need to ensure proper
reimbursement while meeting today’s complex and evolving compliance
requirements. KLAS has consistently ranked these QuadraMed
solutions in the top three positions of their categories since
2005, with EMPI earning the number one position for four of the
past five years.
The annual KLAS report ranks vendors according to performance
scores, which are based on feedback from thousands of healthcare
providers across North America. It recognizes vendors excelling in
their respective market segments, and their leadership in working
with customers to resolve issues and match expectations to
reality.
“Our outstanding KLAS rankings affirm QuadraMed's leadership
position in the marketplace for these solutions and also
demonstrates QuadraMed’s commitment to providing quality products
and services that meet our clients’ changing needs," said Duncan W.
James, QuadraMed’s President and CEO. “In order to meet rigorous
new requirements and qualify for ARRA stimulus incentives,
hospitals today are looking to healthcare technology firms to
provide solutions that improve quality of care, patient safety, and
ensure financial viability. Proven tools like EMPI and Quantim
Coding are having a major impact in helping these organizations
maintain a single, accurate, longitudinal record for patients and
ensure coding compliance for appropriate reimbursement.”
About KLAS
KLAS is a research firm specializing in monitoring and reporting
the performance of healthcare vendors. KLAS’ mission is to improve
delivery by independently measuring vendor performance for the
benefit of healthcare provider partners, consultants, investors,
and vendors. Working together with executives from over 4,500
hospitals and over 2,500 clinics, KLAS delivers timely reports,
trends, and statistics, which provide a solid overview of vendor
performance in the industry. KLAS measures performance of software,
professional services, and medical equipment vendors. For more
information, go to www.KLASresearch.com, email
marketing@KLASresearch.com.
About QuadraMed Corporation
QuadraMed® – (NASDAQ: QDHC) is a leading provider of healthcare
technologies and services that help turn quality care into positive
financial outcomes. QuadraMed provides innovative solutions that
streamline processes, ensure compliance and help healthcare
professionals deliver quality patient care. Behind the Company's
products and services is a staff of 600 professionals whose
experience and dedication have earned QuadraMed the trust and
loyalty of clients at over 2,000 healthcare provider facilities.
For more information about QuadraMed, visit
http://www.quadramed.com.
Cautionary Statement on Risks Associated with QuadraMed
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
that are subject to risks and uncertainties. The words “believe,”
“expect,” “target,” “goal,” “project,” “anticipate,” “predict,”
“intend,” “plan,” “estimate,” “may,” “will,” “should,” “could” and
similar expressions and their negatives are intended to identify
such statements. Forward-looking statements are not guarantees of
future performance, anticipated trends or growth in businesses, or
other characterizations of future events or circumstances and are
to be interpreted only as of the date on which they are made.
QuadraMed undertakes no obligation to update or revise any
forward-looking statement. You should not place undue reliance on
these forward-looking statements. Our actual results could differ
materially from those anticipated in these forward-looking
statements for many reasons, including the risks faced by QuadraMed
described in documents filed with the Securities and Exchange
Commission ("SEC") from time to time. QuadraMed’s SEC filings can
be accessed through the Investor Relations section of our website,
www.quadramed.com, or through the SEC’s EDGAR Database at
www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).
QuadraMed is a registered trademark of QuadraMed Corporation.
All other trademarks are the property of their respective
holders.
Quadramed Corp (MM) (NASDAQ:QDHC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Quadramed Corp (MM) (NASDAQ:QDHC)
Historical Stock Chart
From Aug 2023 to Aug 2024